Cardiovascular Care Market Size, Share, Opportunities, And Trends By Product Type (Cardiac Monitoring Devices, Interventional Cardiology Devices, Cardiac Rhythm Management Devices, Peripheral Vascular Devices, Cardiac Assist Devices, Others), By Service Type (Diagnostic And Imaging Services, Therapeutic Services, Rehabilitation And Recovery Services, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Cardiac Specialty Centers, Others), And By Geography - Forecasts From 2023 To 2028

The cardiovascular care market is estimated to grow at a CAGR of 7.31% during the forecast period.

The cardiovascular care market is an important subset of the healthcare business that focuses on the prevention, diagnosis, and treatment of cardiovascular illnesses. This market includes a diverse variety of medical devices, medications, and services designed to treat illnesses such as heart disease, hypertension, and stroke. With the rising frequency of cardiovascular illnesses worldwide, there is an increased demand for novel and effective cardiovascular care solutions. Medical technology advancements, minimally invasive procedures, and personalised therapies have all contributed to the market's rise. As healthcare systems focus on improving patient outcomes and lowering the burden of cardiovascular illnesses, the cardiovascular care market is critical in protecting heart health and increasing patients' quality of life.

Increasing Prevalence of Cardiovascular Diseases Enhances the Cardiovascular Care Market Growth.

The global incidence of cardiovascular diseases (CVDs) is driving growth in the cardiovascular care market. CVDs are the biggest cause of mortality globally, accounting for nearly 17.9 million deaths per year, according to the World Health Organisation (WHO). The rise in CVD incidence has been attributed to an increase in risk factors such as poor diets, sedentary lifestyles, and cigarette use. As a result, there is a greater need for efficient cardiovascular care solutions, such as medical equipment, medications, and therapies. The rising prevalence of CVDs has prompted investments in research & development to meet the difficulties faced by these illnesses, propelling the cardiovascular care market forward.

Focus on Preventive Cardiology and Early Intervention in Cardiovascular Care Market.

The cardiovascular care market is expanding due to a greater emphasis on preventive cardiology and early intervention tactics. Early diagnosis and control of cardiovascular risk factors, according to studies, can dramatically lower the incidence of heart disease. According to the American Heart Association, lifestyle changes and prompt therapies can prevent approximately 80% of heart disease cases. Healthcare institutions and governments throughout the world are emphasising public health initiatives that encourage healthy practises, frequent screenings, and risk assessments. This proactive approach has increased demand for preventive cardiology measures such as sophisticated diagnostic tools, health monitoring gadgets, and lifestyle management services, which has contributed to the growth of the cardiovascular care market.

Growing Awareness about Cardiovascular Health Boosts the  Cardiovascular Care Market Size.

The cardiovascular care market is benefiting from increased knowledge about cardiovascular health. Increased public awareness of heart disease risk factors and preventative methods has resulted from increased health consciousness and education programmes. People are leading healthier lives, requesting frequent examinations, and taking an active role in reducing cardiovascular risk factors. This increased knowledge has resulted in an increase in demand for cardiovascular care services, such as diagnostic tests, medical equipment, and drugs. Furthermore, healthcare providers are emphasising patient education and preventative actions. Individuals and healthcare systems are prioritising heart health in order to lessen the burden of cardiovascular illnesses, which is driving market growth.

North America is the Market Leader in the Cardiovascular Care Market.

The Cardiovascular Care Market is dominated by North America. Several reasons contribute to the region's prominence. For starters, the increasing frequency of cardiovascular disorders such as heart disease, hypertension, and stroke fuels demand for enhanced cardiovascular care solutions. Second, North America has a well-established healthcare infrastructure as well as cutting-edge medical technology, which allows for the acceptance of novel treatments and procedures. Furthermore, the area places a major emphasis on research and development, which contributes to the continual progress of cardiovascular care. Furthermore, favourable reimbursement policies and rising awareness about preventative cardiovascular health contribute to the market's expansion. North America is at the forefront of cardiovascular care, offering cutting-edge therapies and comprehensive services to patients suffering from cardiovascular problems.

Increasing Investments in Cardiovascular Care R&D in Cardiovascular Care Market.

The cardiovascular care market is expanding rapidly, owing to increased investments in research and development (R&D). Pharmaceutical corporations, medical device makers, and research organisations are investing in the development of novel medications, medical devices, and precision medicine techniques for cardiovascular disorders. The emphasis on research and development strives to improve patient outcomes, meet unmet medical needs, and expand treatment choices for cardiovascular diseases. Consequently, the industry is seeing breakthroughs in diagnostic tools, therapeutic approaches, and personalised therapies, all of which are contributing to the overall growth of the cardiovascular care market.

Key Developments:

• In December 2022, Boston Scientific Corporation and Acotec Scientific Holdings Limited announced that Boston Scientific will make a partial offer to acquire a majority stake in Acotec, a Chinese medical technology company that offers solutions for a variety of interventional procedures, up to a maximum of 65%. At current exchange rates, the proposed price is HK$20 per share, representing a total upfront cash payment consideration of roughly US$523 million for the 65% holding.
• In June 2023, Terumo Aortic has announced the introduction of EXTEND for Thoraflex Hybrid, the only Frozen Elephant Trunk (FET) device approved by the US Food and Drug Administration (FDA) for the treatment of patients with complicated aortic arch illness.
• In March 2022, With the acquisition of Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis). 

Company Products:

• Edwards Lifesciences Corporation: It is a major participant in the cardiovascular care market, specialising in the provision of sophisticated goods and services for the treatment of heart disorders and the improvement of patient outcomes. Their product portfolio encompasses a wide spectrum of cutting-edge heart valve technologies, including transcatheter aortic valve replacement (TAVR) devices and surgical heart valves. These treatments are used to treat valvular heart disorders, and they provide less invasive choices as well as enhanced patient recovery.
• Boston Scientific Corporation: It is a major participant in the cardiovascular care market, providing a wide variety of goods and services to treat various cardiovascular problems and enhance patient outcomes. Their product portfolio comprises a wide range of medical devices, such as coronary stents, drug-eluting stents, and peripheral stents, which are used to treat blocked arteries during percutaneous coronary interventions and peripheral vascular treatments.
• Abbott Laboratories: It is a major participant in the cardiovascular care market, providing a diverse range of goods and services to treat a variety of cardiovascular disorders and enhance patient outcomes. Their product portfolio comprises a wide range of medical devices and technology used in percutaneous coronary procedures to treat blocked arteries, such as vascular stents, balloons, and guidewires.

Key Segment:

• By Product Type
  • Cardiac Monitoring Devices
  • Interventional Cardiology Devices
  • Cardiac Rhythm Management Devices
  • Peripheral Vascular Devices
  • Cardiac Assist Devices
  • Others 
• By Service Type
  • Diagnostic And Imaging Services
  • Therapeutic Services
  • Rehabilitation And Recovery Services
  • Others 
• By End-User
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cardiac Specialty Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain   
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Sources

2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. CARDIOVASCULAR CARE MARKET, BY PRODUCT TYPE

5.1. Introduction

5.2. Cardiac Monitoring Devices

5.3. Interventional Cardiology Devices

5.4. Cardiac Rhythm Management Devices

5.5. Peripheral Vascular Devices

5.6. Cardiac Assist Devices

5.7. Others                  

6. CARDIOVASCULAR CARE MARKET, BY SERVICE TYPE

6.1. Introduction

6.2. Diagnostic and Imaging Services

6.3. Therapeutic Services

6.4. Rehabilitation and Recovery Services

6.5. Others               

7. CARDIOVASCULAR CARE MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals and Clinics

7.3. Ambulatory Surgical Centers

7.4. Diagnostic Centers

7.5. Cardiac Specialty Centers

7.6. Others 

8. CARDIOVASCULAR CARE MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia 

8.6.6. Taiwan

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Medtronic plc

10.2. Abbott Laboratories

10.3. Boston Scientific Corporation

10.4. Edwards Lifesciences Corporation

10.5. Johnson & Johnson

10.6. Siemens Healthineers AG

10.7. Cardinal Health, Inc.

10.8. Terumo Corporation

10.9. Becton, Dickinson and Company (BD)

10.10. Koninklijke Philips N.V. 

Medtronic Plc

Abbott Laboratories

Boston Scientific Corporation

Edwards Lifesciences Corporation

Johnson & Johnson

Siemens Healthineers Ag

Cardinal Health, Inc.

Terumo Corporation

Becton, Dickinson And Company (Bd)

Koninklijke Philips N.V.